BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22078814)

  • 1. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.
    Barbe C; Murat A; Dupas B; Ruszniewski P; Tabarin A; Vullierme MP; Penfornis A; Rohmer V; Baudin E; Le Rhun M; Gaye D; Marcus C; Cadiot G;
    Dig Liver Dis; 2012 Mar; 44(3):228-34. PubMed ID: 22078814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of nonfunctioning pancreatic endocrine tumors in the context of multiple endocrine neoplasia type 1 syndrome.
    Botsios D; Vasiliadis K; Tsalis K; Iordanidis F; Megalopoulos A; Tsachalis T; Blouhos K; Betsis D
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):257-62. PubMed ID: 17925918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1.
    Hellman P; Hennings J; Akerström G; Skogseid B
    Br J Surg; 2005 Dec; 92(12):1508-12. PubMed ID: 16231278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy.
    Borbath I; Van Beers BE; Lonneux M; Schoonbroodt D; Geubel A; Gigot JF; Deprez PH
    Pancreatology; 2005; 5(6):553-61. PubMed ID: 16113592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging.
    Ramsay D; Marshall M; Song S; Zimmerman M; Edmunds S; Yusoff I; Cullingford G; Fletcher D; Mendelson R
    Australas Radiol; 2004 Jun; 48(2):154-61. PubMed ID: 15230749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions.
    Kim YC; Choi JY; Chung YE; Bang S; Kim MJ; Park MS; Kim KW
    AJR Am J Roentgenol; 2010 Oct; 195(4):947-52. PubMed ID: 20858823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
    Daskalakis K; Tsoli M; Alexandraki KI; Angelousi A; Chatzellis E; Tsolakis AV; Karoumpalis I; Kolomodi D; Kassi E; Kaltsas G
    Horm Metab Res; 2019 Sep; 51(9):580-585. PubMed ID: 31295747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based Cohort.
    van Beek DJ; Verkooijen HM; Nell S; Bonsing BA; van Eijck CH; van Goor H; Hoogwater FJH; Nieveen van Dijkum EJM; Kazemier G; Dejong CHC; Brosens LAA; Wessels FJ; Borel Rinkes IHM; Valk GD; Vriens MR
    Neuroendocrinology; 2021; 111(8):705-717. PubMed ID: 32721974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
    Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases.
    Chatzipantelis P; Salla C; Konstantinou P; Karoumpalis I; Sakellariou S; Doumani I
    Cancer; 2008 Aug; 114(4):255-62. PubMed ID: 18618505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of the utility of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic masses, using a 22-gauge or 25-gauge needle system: a multicenter experience.
    Yusuf TE; Ho S; Pavey DA; Michael H; Gress FG
    Endoscopy; 2009 May; 41(5):445-8. PubMed ID: 19418399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1.
    Gauger PG; Scheiman JM; Wamsteker EJ; Richards ML; Doherty GM; Thompson NW
    Br J Surg; 2003 Jun; 90(6):748-54. PubMed ID: 12808627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
    Canto MI; Goggins M; Hruban RH; Petersen GM; Giardiello FM; Yeo C; Fishman EK; Brune K; Axilbund J; Griffin C; Ali S; Richman J; Jagannath S; Kantsevoy SV; Kalloo AN
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):766-81; quiz 665. PubMed ID: 16682259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI.
    Noone TC; Hosey J; Firat Z; Semelka RC
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):195-211. PubMed ID: 15763695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What extent of pancreatic resection do patients with MEN-1 require?
    Adkisson CD; Stauffer JA; Bowers SP; Raimondo M; Wallace MB; Riegert-Johnson DL; Asbun HJ
    JOP; 2012 Jul; 13(4):402-8. PubMed ID: 22797396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
    Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
    Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
    Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
    Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.